Patent · US Active

Methods targeting miR-128 for regulating cholesterol/lipid metabolism

US9045749B2 · kind B2 · utility

2Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 13, 2012
Grant dateJun 2, 2015
Priority date—
Expiry dateJan 13, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.